Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 2/20 | 0.63 |
| ▸ | CTSB | P07858 | 2/20 | 0.63 |
| ▸ | DPP3 | Q9NY33 | 5/20 | 0.62 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.56 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.56 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.56 |
| ▸ | F13A1 | P00488 | 2/20 | 0.54 |
| ▸ | TGM2 | P21980 | 2/20 | 0.54 |
| ▸ | KISS1R | Q969F8 | 4/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.49 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.49 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32681277 | 0.97 | CAPN1 (0.59) | CAPN1CTSBDPP3NTSR2NTSR1 | |
| SCHEMBL32681271 | 0.96 | DPP3 (0.66) | CAPN1CTSBDPP3NTSR2NTSR1 | |
| SCHEMBL32681280 | 0.90 | DPP3 (0.59) | CAPN1CTSBDPP3NTSR2NTSR1 | |
| SCHEMBL31070712 | 0.90 | DPP3 (0.69) | CAPN1CTSBDPP3NTSR2NTSR1 | |
| SCHEMBL30483549 | 0.89 | DPP3 (0.58) | CAPN1CTSBDPP3NTSR2NTSR1 | |
| SCHEMBL30735734 | 0.88 | CXCR4 (0.58) | CAPN1CTSBDPP3NTSR2NTSR1 | |
| SCHEMBL14665051 | 0.88 | CAPN1 (0.60) | CAPN1CTSBDPP3KISS1ROPRM1 | |
| SCHEMBL29380301 | 0.87 | CAPN1 (0.58) | CAPN1CTSBDPP3NTSR2NTSR1 | |
| SCHEMBL30051839 | 0.87 | DPP4 (0.54) | CAPN1CTSBDPP3NTSR2NTSR1 | |
| SCHEMBL32681272 | 0.86 | DPP3 (0.62) | CAPN1CTSBDPP3NTSR2NTSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260060913-A1 | BIOACTIVE WALNUT PEPTIDES FOR TREATING HAIR LOSS | L'OREAL (FR) | 2026-03-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060913-A1 | BIOACTIVE WALNUT PEPTIDES FOR TREATING HAIR LOSS | TYR, CUTA, ARGLU1 | CAPN1 1600/4885CTSB 2089/4885DPP3 1619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.